Outsourcing

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Articles

Experts share best practices in designing, manufacturing, and scaling up dry powder inhaler and metered dose inhaler drug–device combination products for inhalation drug delivery. 

Considerations for DPIs and MDIs in Inhalation Drug Delivery

Meg Rivers is the former senior editor for 

Navigating a complex global regulatory landscape involves upfront research into the expectations of the different regulatory bodies, thorough documentation of every step of the API manufacturing process, and good communication. 

Global Regulatory Approach to API Manufacturing

Between dosage form versatility, product stability, lack of storage restrictions or need to refrigerate, and an easier means of purification, small-molecule APIs present an appealing market niche.

API Development and Manufacturing: Advantages of Working with Small Molecules

Aceto will acquire A&C Bio Buffer, including the company’s custom buffer and chemical blend portfolio.

Aceto Acquires A&C Bio Buffer, Expanding GMP Product Lines in Biopharma

Avid Bioservices is building a viral vector development and manufacturing facility near its existing biologics manufacturing facility in California. 

Avid Bioservices Expands into Viral Vector Development and Manufacturing Services

AGC Biologics is expanding manufacturing capacity at its Heidelberg, Germany, facility for plasmid DNA and messenger RNA.

AGC Bio Boosts Manufacturing Capacity for pDNA and mRNA at Heidelberg Facility

Febles will oversee day-to-day aseptic manufacturing at Pharmaceutics International, Inc.

Pii Hires Roberto Almodóvar Febles as Head of Aseptic Operations

Quotient Sciences is investing £6.3 million ($8.68 million) into their drug substance manufacturing capabilities.

Quotient Sciences Makes Multi-Million Dollar Investment to Expand Drug Substance Manufacturing Facility

AGC Biologics has broken ground on a new multipurpose facility in Copenhagen, Denmark, that will increase capacity.

AGC Biologics Breaks Ground on New Multipurpose Facility in Denmark

Lonza plans to establish drug product manufacturing capabilities at is site in Guangzhou, China, to produce clinical trial and commercial supply in the country.

Contract Manufacturing Services